Erika Siren
Erika Siren lives in Vancouver, British Columbia, where she is currently a PhD Candidate in the University of British Columbia’s Department of Chemistry. Under the supervision of Dr. Jayachandran Kizhakkedathu, Erika develops biomaterials that can be used to manipulate the immune system. Away from the bench, Erika has a keen interest in the challenges that face the commercialization, policy development and public perception of therapies in regenerative medicine. Connect with Erika on Linkedin: https://www.linkedin.com/in/erika-siren/
Posts by: Erika
Breathing new life into gut regeneration with living bandages
At first pass, the skin and the gut are not so different: both are lined with an outer layer of cells that serve as the first line of protection from biological, chemical and physical wear-and-tear. Accordingly, both the gut and skin are subject to tissue breakdown whether it be from invasive bacteria, rapid changes in […]
The great experiment: CAR T in Canada
September 5th, 2018, marked a momentous day for Canadian health care as Novartis announced Health Canada’s approval of Kymriah™, the first genetically manipulated cell therapy to be approved in Canada. With the ability of CAR Ts like Kymriah to treat and, potentially cure, otherwise hard-to-treat cancers such as leukemia and lymphoma, Canadian taxpayers will finally […]
Comments